JEMPERLI
JEMPERLI
Approved
DIN Number
02523434
Drug Class
Human
Market Date
Feb 22, 2022
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02523434
AIG Number0163298001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L01FF07 DOSTARLIMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
DOSTARLIMABActive
Strength: 50 MG / ML
Monograph: DOSTARLIMAB